Board to consider Dividend

| Updated on May 14, 2018 Published on May 14, 2018

Bal Pharma Ltd has informed BSE that the meeting of Board of Directors of the Company is scheduled to be held on May 29, 2018, inter alia, will be considering:

1. Approval of Audited Stand Alone and Consolidated financial results of the Company for the quarter and year ended March 31, 2018.

2. Appropriation of profits including recommendation of dividend, if any, for the financial year 2017-18.

Further, pursuant to Prohibition of Insider Trading Regulations, 2015 of SEBI and as per the provisions of Code of Conduct of the Company, the trading window on the designated employees of the Company and their immediate relatives will remain closed from May 14, 2018 up to May 30, 2018.

Pdf Link: Board to consider Dividend

Source : BSE - www.bseindia.com

Published on May 14, 2018
This article is closed for comments.
Please Email the Editor